Alpine Immune Sciences

Acquired
Seattle, Washington, US

Alpine Immune Sciences develops treatments for inflammatory diseases and cancer.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Founded
2015
Type
Corporation Seattle business license
Employees
51–200
Status
Acquired
Registered name
Ais Operating Co Inc Seattle business license
Stage
Acquired
Members see funding amounts.
.

Is this your organization? Claim it

InduPro names Prakash Raman, Ph.D. CEO; Amanda J. Redig, M.D., Ph.D. serves as CMO with deep biopharma backgrounds

This page profiles InduPro's leadership, highlighting CEO Prakash Raman, Ph.D., and CMO Amanda J. Redig, M.D., Ph.D., summarizing their education and extensive biopharma and drug development experience. It emphasizes Raman’s prior roles at Ribon Therapeutics, Flagship Pioneering, and Novartis and his track record in business development, collaborations, and advancing drug candidates to clinical testing.

Frazier Healthcare Partners closes $1.3 billion early‑stage biotech fund after leading many 2024 deals and scoring big exits

Frazier Healthcare Partners has closed a $1.3 billion venture fund to back early-stage biotech startups, building on a busy 2024 where it led nearly a third of 17 deals and scored major exits like Scorpion Therapeutics’ $2.5 billion drug sale to Eli Lilly. The fund follows other recent life‑sciences raises and arrives as overall biotech VC funding has declined.

See all 12 news stories about Alpine Immune Sciences.

Online